Atlas Trials

Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.

Clinical trial NCT04949386 · UNKNOWN

Trial details

NCT number
NCT04949386
Sponsor
SolAeroMed Inc.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Post Acute COVID-19 SyndromeLong COVIDCOVID-19 Respiratory Infection
Start date
2021-09-01
Primary completion
2021-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.